NDAC 33.1-24-05-312
Standards for health care facilities managing noncreditable hazardous waste pharmaceuticals
Cite as N.D. Admin. Code § 33.1-24-05-312
1.
Notification and withdrawal from sections 33.1-24-05-310 through 33.1-24-05-320 for health
care facilities managing hazardous waste pharmaceuticals.
a.
Notification. A health care facility must notify the department using the site identification
form (environmental protection agency form 8700-12), that it is a health care facility
operating under sections 33.1-24-05-310 through 33.1-24-05-320. A health care facility is
not required to fill out box 10.B. (waste codes for federally regulated hazardous waste) of
the site identification form with respect to its hazardous waste pharmaceuticals. A health
care facility must submit a separate notification (site identification form) for each site or
environmental protection agency identification number.
(1)
A health care facility that already has an environmental protection agency
identification number shall notify the department using the site identification form
(environmental protection agency form 8700-12) that it is a health care facility as
part of its next biennial report, if it is required to submit one; or if not required to
submit a biennial report, within sixty days of July 1, 2021, or within sixty days of
becoming subject to this subpart.
(2)
A health care facility that does not have an environmental protection agency
identification number shall obtain one by notifying the department, using the site
identification form (environmental protection agency form 8700-12), that it is a
health care facility as part of its next biennial report, if it is required to submit one; or
if not required to submit a biennial report, within sixty days of July 1, 2021, or within
sixty days of becoming subject to this subpart.
(3)
A health care facility must keep a copy of its notification on file for as long as the
health care facility is subject to sections 33.1-24-05-310 through 33.1-24-05-320.
b.
Withdrawal. A health care facility that operated under sections 33.1-24-05-310 through
33.1-24-05-320, but is no longer subject to these requirements, because it is a very small
quantity generator operating under section 33.1-24-03-26 and elects to withdraw from
this subpart, shall notify the department using the site identification form (environmental
protection agency form 8700-12) that it is no longer operating under these sections. A
health care facility is not required to fill out box 10.B. (waste codes for federally regulated
hazardous waste) of the site identification form with respect to its hazardous waste
pharmaceuticals. A health care facility shall submit a separate notification (site
identification form) for each environmental protection agency identification number.
(1)
A health care facility must submit the site identification form notifying that it is
withdrawing from these requirements before it begins operating under the conditions
for exemption in section 33.1-24-03-26.
(2)
A health care facility shall keep a copy of its withdrawal on file for three years from
the date of signature on the notification of its withdrawal.
2.
Training of personnel managing noncreditable hazardous waste pharmaceuticals at
health care facilities. A health care facility shall ensure all personnel that manage
noncreditable hazardous waste pharmaceuticals are thoroughly familiar with proper waste
handling and emergency procedures relevant to their responsibilities during normal facility
operations and emergencies.
3.
Hazardous waste determination for noncreditable pharmaceuticals. A health care facility
that generates a solid waste that is a noncreditable pharmaceutical shall determine whether
that pharmaceutical is a hazardous waste pharmaceutical (i.e., it exhibits a characteristic
identified in sections 33.1-24-02-10 through 33.1-24-02-14 or is listed in sections
33.1-24-02-15 through 33.1-24-02-19) to determine whether the waste is subject to the
requirements in sections 33.1-24-05-310 through 33.1-24-05-320. A health care facility may
choose to manage its nonhazardous waste pharmaceuticals as noncreditable hazardous
waste pharmaceuticals under these requirements.
4.
Standards for containers used to accumulate noncreditable hazardous waste
pharmaceuticals at health care facilities.
a.
A health care facility shall place noncreditable hazardous waste pharmaceuticals in a
container that is structurally sound, compatible with its contents, and that lacks evidence
of leakage, spillage, or damage that could cause leakage under reasonably foreseeable
conditions.
b.
A health care facility that manages ignitable or reactive noncreditable hazardous waste
pharmaceuticals, or that mixes or commingles incompatible noncreditable hazardous
waste pharmaceuticals shall manage the container so that it does not have the potential
to:
(1)
Generate extreme heat or pressure, fire or explosion, or violent reaction;
(2)
Produce uncontrolled toxic mists, fumes, dusts, or gases in sufficient quantities to
threaten human health;
(3)
Produce uncontrolled flammable fumes or gases in sufficient quantities to pose a
risk of fire or explosions;
(4)
Damage the structural integrity of the container of noncreditable hazardous waste
pharmaceuticals; or
(5)
Through other like means threaten human health or the environment.
c.
A health care facility shall keep containers of noncreditable hazardous waste
pharmaceuticals closed and secured in a manner that prevents unauthorized access to
its contents.
d.
A health care facility may accumulate noncreditable hazardous waste pharmaceuticals
and nonhazardous noncreditable waste pharmaceuticals in the same container, except
that noncreditable hazardous waste pharmaceuticals prohibited from being combusted
because of the dilution prohibition of section 33.1-24-05-252 must be accumulated in
separate containers and labeled with all applicable hazardous waste numbers, i.e.,
hazardous waste codes.
5.
Labeling containers used to accumulate
noncreditable hazardous waste
pharmaceuticals at health care facilities. A health care facility shall label or clearly mark
each container of noncreditable hazardous waste pharmaceuticals with the phrase
"Hazardous Waste Pharmaceuticals".
6.
Maximum accumulation time for noncreditable hazardous waste pharmaceuticals at
health care facilities.
a.
A health care facility may accumulate noncreditable hazardous waste pharmaceuticals
on site for one year or less without a permit.
b.
A health care facility that accumulates noncreditable hazardous waste pharmaceuticals
onsite shall demonstrate the length of time that the noncreditable hazardous waste
pharmaceuticals have been accumulating, starting from the date it first becomes a waste.
A health care facility may make this demonstration by any of the following methods:
(1)
Making or labeling the container of noncreditable hazardous waste pharmaceuticals
with the date that the noncreditable hazardous waste pharmaceuticals became a
waste;
(2)
Maintaining an inventory system that identifies the date the noncreditable hazardous
waste pharmaceuticals being accumulated first became a waste; or
(3)
Placing the noncreditable hazardous waste pharmaceuticals in a specific area and
identifying the earliest date any of the noncreditable hazardous waste
pharmaceuticals in the area became a waste.
7.
Land disposal restrictions for noncreditable hazardous waste pharmaceuticals. The
noncreditable hazardous waste pharmaceuticals generated by a health care facility are
subject to the land disposal restrictions of sections 33.1-24-05-250 through 33.1-24-05-309. A
health care facility that generates noncreditable hazardous waste pharmaceuticals shall
comply with the land disposal restrictions in accordance with subsection 1 of section
33.1-24-05-256 requirements, except that it is not required to identify the hazardous waste
numbers (i.e., hazardous waste codes) on the land disposal restrictions notification.
8.
Procedures for health care facilities for managing rejected shipments of noncreditable
hazardous waste pharmaceuticals. A health care facility that sends a shipment of
noncreditable hazardous waste pharmaceuticals to a designated facility with the
understanding that the designated facility can accept and manage the waste, and later
receives that shipment back as a rejected load in accordance with the manifest discrepancy
provisions of section 33.1-24-05-39 may accumulate the returned noncreditable hazardous
waste pharmaceuticals onsite for up to an additional ninety days provided the rejected or
returned shipment is managed in accordance with subsections 4 and 5. Upon receipt of the
returned shipment, the health care facility shall:
a.
Sign either:
(1)
Item 18c of the original manifest, if the original manifest was used for the return
shipment; or
(2)
Item 20 of the new manifest, if a new manifest was used for the returned shipment.
b.
Provide the transporter a copy of the manifest;
c.
Within thirty days of receipt of the rejected shipment, send a copy of the manifest to the
designated facility that returned the shipment to the health care facility; and
d.
Within ninety days of receipt of the rejected shipment, transport or offer for transport the
returned shipment in accordance with the shipping standards of subsection 1 of section
33.1-24-05-318.
9.
Reporting by health care facilities for noncreditable hazardous waste pharmaceuticals.
a.
Biennial reporting by health care facilities. Health care facilities are not subject to biennial
reporting requirements under section 33.1-24-03-14, with respect to noncreditable
hazardous waste pharmaceuticals managed under sections 33.1-24-05-310 through
33.1-24-05-320.
b.
Exception reporting by health care facilities for a missing copy of the manifest.
(1)
For shipments from a health care facility to a designated facility, if a health care
facility does not receive a copy of the manifest with the signature of the owner or
operator of the designated facility within sixty days of the date of the noncreditable
hazardous waste pharmaceuticals were accepted by the initial transporter, the
health care facility shall submit:
(a)
A legible copy of the original manifest, indicating the health care facility has not
received confirmation of delivery, to the department; and
(b)
A handwritten or typed note on the manifest itself, or on an attached sheet of
paper, stating the return copy was not received and explaining the efforts taken
to locate the noncreditable hazardous waste pharmaceuticals and the results
of those efforts.
(2)
For shipments rejected by the designated facility and shipped to an alternate facility,
if a health care facility does not receive a copy of the manifest for a rejected
shipment of the noncreditable hazardous waste pharmaceuticals that is forwarded
by the designated facility to an alternate facility using appropriate manifest
procedures, with the signature of the owner or operator of the alternate facility,
within sixty days of the date the noncreditable hazardous waste was accepted by
the initial transporter forwarding the shipment of noncreditable hazardous waste
pharmaceuticals from the designated facility to the alternate facility, the health care
facility shall submit:
(a)
A legible copy of the original manifest, indicating the health care facility has not
received confirmation of delivery, to the department; and
(b)
A handwritten or typed note on the manifest itself, or on an attached sheet of
paper, stating the return copy was not received and explaining the efforts taken
to locate the noncreditable hazardous waste pharmaceuticals and the results
of those efforts.
c.
Additional reports. The department may require health care facilities to furnish additional
reports concerning the quantities and disposition of noncreditable hazardous waste
pharmaceuticals.
10.
Recordkeeping by health care facilities for
noncreditable hazardous waste
pharmaceuticals.
a.
A health care facility shall keep a copy of each manifest signed in accordance with
subsection 1 of section 33.1-24-03-07 for three years or until it receives a signed copy
from the designated facility which received the noncreditable hazardous waste
pharmaceuticals. This signed copy must be retained as a record for at least three years
from the date the waste was accepted by the initial transporter.
b.
A health care facility shall keep a copy of each exception report for a period of at least
three years from the date of the report.
c.
A health care facility shall keep records of any test results, waste analyses, or other
determinations made to support its hazardous waste determination consistent with
subsection 6 of section 33.1-24-03-02 for at least three years from the date the waste
was last sent to an onsite or offsite treatment, storage, or disposal. A health care facility
that manages all of its noncreditable nonhazardous waste pharmaceuticals as
noncreditable hazardous waste pharmaceuticals is not required to keep documentation
of hazardous waste determinations.
d.
The periods of retention referred to in this section are extended automatically during the
course of any unresolved enforcement action regarding the regulated activity, or as
requested by the department.
e.
All records must be readily available upon request by an inspector.
11.
Response to spills of noncreditable hazardous waste pharmaceuticals at health care
facilities. A health care facility immediately shall contain all spills of noncreditable hazardous
waste pharmaceuticals and manage the spill cleanup materials as noncreditable hazardous
waste pharmaceuticals in accordance with the requirements in sections 33.1-24-05-310
through 33.1-24-05-320.
12.
Accepting noncreditable hazardous waste pharmaceuticals from an offsite health care
facility that is a very small quantity generator. A health care facility may accept
noncreditable hazardous waste pharmaceuticals from an offsite health care facility that is a
very small quantity generator under section 33.1-24-03-26 without a permit or without having
interim status, provided the receiving health care facility:
a.
Is under the control of the same person, as defined in section 33.1-24-03-26, as the very
small quantity generator health care facility that is sending the noncreditable hazardous
waste pharmaceuticals offsite ("control", for the purposes of this section means the
power to direct the policies of the health care facility, whether by the ownership of stock,
voting rights, or otherwise, except that contractors who operate health care facilities on
behalf of a different person as defined in section 33.1-24-03-26 may not be deemed to
"control" such health care facilities) or has a contractual or other documented business
relationship whereby the receiving health care facility supplies pharmaceuticals to the
very small quantity generator health care facility;
b.
Is operating under this section for the management of its noncreditable hazardous waste
pharmaceuticals;
c.
Manages the noncreditable hazardous waste pharmaceuticals that it receives from offsite
in compliance with sections 33.1-24-05-310 through 33.1-24-05-320; and
d.
Keeps records of the noncreditable hazardous waste pharmaceuticals shipments it
receives from offsite for three years from the date that the shipment is received.